Moshe Sarfaty
Directeur Général chez LS Biopath, Inc.
Postes actifs de Moshe Sarfaty
Sociétés | Poste | Début | Fin |
---|---|---|---|
LS Biopath, Inc.
LS Biopath, Inc. Medical SpecialtiesHealth Technology LS Biopath, Inc. provides a solution for real-time imaging of breast cancer surgical margins. The private company is based in Saratoga, CA. Breast-conserving-surgery is the most common treatment for breast tumors, and obtaining tumor-free surgical margins decreases the incidence of local recurrences. The company has developed Clearedge, an intra-operative imaging device that can effectively assess breast tissue margins during breast cancer surgery. The CEO of the company is Moshe Sarfaty. | Directeur/Membre du Conseil | - | - |
Directeur Général | 01/01/2009 | - | |
President | - | - | |
Aristagora VC Israel Management Ltd. | Private Equity Investor | 01/07/2020 | - |
Historique de carrière de Moshe Sarfaty
Anciens postes connus de Moshe Sarfaty
Sociétés | Poste | Début | Fin |
---|---|---|---|
Krypton Venture Capital Ltd.
Krypton Venture Capital Ltd. Investment ManagersFinance Krypton Venture Capital Ltd. (Krypton Venture Capital) is a venture capital firm founded in 2014 by Moshe Sarfaty. The firm is headquartered in Bnei Brak, Israel. | Fondateur | 01/01/2013 | 02/07/2020 |
Formation de Moshe Sarfaty
Yale University | Undergraduate Degree |
Statistiques
Internationale
Israël | 3 |
Etats-Unis | 3 |
Opérationnelle
Founder | 1 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorielle
Finance | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Krypton Venture Capital Ltd.
Krypton Venture Capital Ltd. Investment ManagersFinance Krypton Venture Capital Ltd. (Krypton Venture Capital) is a venture capital firm founded in 2014 by Moshe Sarfaty. The firm is headquartered in Bnei Brak, Israel. | Finance |
LS Biopath, Inc.
LS Biopath, Inc. Medical SpecialtiesHealth Technology LS Biopath, Inc. provides a solution for real-time imaging of breast cancer surgical margins. The private company is based in Saratoga, CA. Breast-conserving-surgery is the most common treatment for breast tumors, and obtaining tumor-free surgical margins decreases the incidence of local recurrences. The company has developed Clearedge, an intra-operative imaging device that can effectively assess breast tissue margins during breast cancer surgery. The CEO of the company is Moshe Sarfaty. | Health Technology |
Aristagora VC Israel Management Ltd. | Finance |
- Bourse
- Insiders
- Moshe Sarfaty
- Expérience